tradingkey.logo

Embecta jumps on quarterly results beat

ReutersAug 8, 2025 3:12 PM

Shares of medical device maker Embecta EMBC.O rise 15.1% to $11.92

Company posts Q3 revenue of $295.5 million compared with analysts' estimates of $278.2 million

Reports Q3 adj. profit of $1.12 per share vs estimates of 78 cents

Company narrows its 2025 revenue forecast to a range of $1.078 billion to $1.085 billion compared to its prior range of $1.073 billion to $1.09 billion

"Q3 was a strong quarter for Embecta, reflecting solid commercial execution, aided in part by the timing of customer order," says CEO Devdatt Kurdikar

Including session moves, stock down 41.4% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI